Westwater (WWR) traded flat 0 % during a 24 hours period ending at 10:01 PM Central Europe on Tuesday 27th. One Westwater stock can currently be bought for about USD 0.42 on popular exchanges. Current supply of Westwater stocks is 128.6 mn. Westwater has a current market capitalization of USD 53.2 mn and approximately USD 269.1 k worth of Westwater was traded on exchanges in the last 24 hours. Since last month end, Westwater has traded -21.15 % down. Simple moving average of last 200 days is at USD 0.64. The highest price of past 52 weeks was recorded at USD 1.54 on 10/30/2025. 52 weeks low was at USD 0.38 on 07/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Verrica (VRCA) traded down -3.12 % and now trades at USD 3.47. Verrica has a market capitalisation of USD 61.3 mn.

  • Lanzatech Global (LNZA) traded down -1.04 % and now trades at USD 4.99. Lanzatech Global has a market capitalisation of USD 63 mn. Lanzatech Global has a current price to earnings ratio of 0.22.

  • Tecogen /Waltham Ma (TGEN) traded down -8.57 % and now trades at USD 2.1. Tecogen /Waltham Ma has a market capitalisation of USD 63.4 mn.

  • Citius Oncology (CTOR) traded up 2.76 % and now trades at USD 0.61. Current market capitalisation for Citius Oncology is USD 61.3 mn. Citius Oncology, Inc. reported preliminary, unaudited sales data for its drug LYMPHIR® during the fiscal fourth quarter of 2026. According to a company filing and a concurrent press release, unit sales to U.S. wholesalers more than doubled compared to the previous quarter, reflecting expanded commercial coverage and sustained institutional demand. The company noted that it has reached more than half of its target to place LYMPHIR on the formularies of 100 priority institutions by year‑end. Management expects the momentum to continue into fiscal 2027, with deeper penetration into academic and community treatment centers and ongoing growth as the therapy becomes further established for cutaneous T‑cell lymphoma. Citius plans to release full fourth‑quarter and annual 2026 results in December in its Form 10‑K.

  • Fortress Biotech (FBIO) traded down -3.11 % and now trades at USD 1.93. Fortress Biotech has a market capitalisation of USD 62.7 mn. Fortress Biotech has a current price to earnings ratio of 0.59.

About Westwater

Westwater Resources, Inc. is an exploration and development company based in the United States with a focus on finding essential minerals for clean energy production. The company specializes in exploring and producing lithium and uranium metals, which are widely used in various battery and industrial applications. Westwater Resources serves its customers in both the United States and Turkey. You can find more information about their activities and offerings on their website, www.westwaterresources.net , and they are listed on the NYSE MKT stock exchange.